Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE invendo medical
Top-notch New York-based hospitals are first to make new endoscope for colon cancer screening available to U.S. patients
NEW YORK and KISSING, Germany, March 11, 2013 /PRNewswire/ -- invendo medical announced today that the company entered the U.S. market by installing first systems at NYU Langone Medical Center and NewYork-Presbyterian Hospital/Columbia University Medical Center– two of the most renowned GI endoscopy centers. First U.S. patients have already undergone a colonoscopy with the new C20™ colonoscopy system including the SC20™ single-use colonoscope.
This initial entry of the US market follows a special 510(k) clearance by the FDA which cleared several important product improvements for marketing.
The invendoscope™ SC20 has several features that are new to the field of colonoscopy:
"We are proud that two such highly regarded clinical institutions have decided to offer their patients an additional option for colonoscopy," said John J. Cifarelli, EVP Global Markets of invendo medical. "We are enthusiastic about the potential of our colonoscopy system and are confident that many US patients will appreciate the benefits of the invendo system when they have to decide which screening method would suit them best."
About invendo medical - www.invendo-medical.com
Based in New York, U.S.A. and Kissing (near Munich), Germany, invendo medical is a leading developer of disposable endoscopy products in the field of gastroenterology that are hygienically safe and employ "no manual push" computer-assisted, gentle advancement technology.
©2012 PR Newswire. All Rights Reserved.